Your browser doesn't support javascript.
loading
Prognostic factors in postoperative patients with cutaneous melanoma: a systematic review and meta-analysis.
Xia, Qi; Ma, Qinghua; Zhu, Jiuqun; Gu, Lu; Zhou, Fengling.
  • Xia Q; Department of PICC, Day Chemotherapy Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China Chengdu 610072, Sichuan, China.
  • Ma Q; Department of Nursing, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China Chengdu 610072, Sichuan, China.
  • Zhu J; Department of Pharmacy, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China Chengdu 610072, Sichuan, China.
  • Gu L; Department of Radiation, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China Chengdu 610072, Sichuan, China.
  • Zhou F; Department of Pediatrics, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China Chengdu 610072, Sichuan, China.
Am J Cancer Res ; 14(5): 1947-1956, 2024.
Article en En | MEDLINE | ID: mdl-38859868
ABSTRACT
Cutaneous melanoma is a prevalent tumor associated with a poor prognosis. This systematic review and meta-analysis aimed to identify and evaluate prognostic factors for patients with cutaneous melanoma following surgery, thereby providing crucial insights for enhancing patient outcomes. We searched PubMed, Embase, Cochrane Library, CINAHL, and Web of Science for studies on postoperative prognostic factors of cutaneous melanoma up to March 2024. Literature screening, data extraction, and quality assessment were performed, followed by meta-analysis using RevMan 5.3 software. Trial Sequential Analysis (TSA) was conducted with Stata 17 software to verify the robustness of the findings. Eleven studies encompassing 27,352 patients were included. The meta-analysis identified several prognostic factors impacting disease-specific survival post-surgery age over 50 years (HR=1.05, 95% CI 1.02-1.08), female gender (HR=0.71, 95% CI 0.57-0.87), Breslow thickness greater than 2 mm (HR=1.11, 95% CI 1.06-1.17), presence of ulceration (HR=2.06, 95% CI 1.63-2.60), and positive sentinel lymph node (HR=3.03, 95% CI 2.50-3.66). TSA confirmed the adequacy of the sample size. Aggressive treatment strategies are recommended for patients exhibiting these characteristics to improve prognosis and extend 5-year survival rates.
Palabras clave